A Phase 2 trial of YH25724 for Non-alcoholic steatohepatitis
Latest Information Update: 24 Jan 2022
At a glance
- Drugs YH 25724 (Primary)
- Indications Non-alcoholic steatohepatitis
- Focus Therapeutic Use
Most Recent Events
- 24 Jan 2022 New trial record